Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of TA-650 (infliximab) in patients with psoriasis
jRCT2080220314Phase 3
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of infliximab in psoriasis, sponsored by Mitsubishi Tanabe Pharma Corporation.
02
Drugs
infliximab
03
Conditions
psoriasis
Beyond the preview
Go deeper on jRCT2080220314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220314.